[HTML][HTML] Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
M Zamani, H Poustchi, Z Mohammadi, S Dalvand… - BMC public health, 2022 - Springer
Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.
M Zamani, H Poustchi, Z Mohammadi… - BMC Public …, 2022 - europepmc.org
Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
M Zamani, H Poustchi, Z Mohammadi… - BMC Public …, 2022 - search.proquest.com
Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
M Zamani, H Poustchi, Z Mohammadi… - BMC public …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
[HTML][HTML] Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
M Zamani, H Poustchi, Z Mohammadi… - BMC Public …, 2022 - ncbi.nlm.nih.gov
Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.
M Zamani, H Poustchi, Z Mohammadi, S Dalvand… - 2022 - cabidigitallibrary.org
Background: The first large serosurvey in Iran found a SARS-CoV-2 antibody
seroprevalence of 17.1% among the general population in the first wave of the epidemic by …
seroprevalence of 17.1% among the general population in the first wave of the epidemic by …
[HTML][HTML] Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
M Zamani, H Poustchi… - BMC Public …, 2022 - bmcpublichealth.biomedcentral.com
The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence of 17.1%
among the general population in the first wave of the epidemic by April, 2020. The purpose …
among the general population in the first wave of the epidemic by April, 2020. The purpose …
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.
M Zamani, H Poustchi, Z Mohammadi… - BMC Public …, 2022 - europepmc.org
Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …